# James Moon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-moon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 74,519 |
| Field | Cardiac Imaging and Diagnostics |
| h-index | 134 |
| i10-index | 572 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5003474421 |
| ORCID iD | https://orcid.org/0000-0001-8071-1491 |
| Works | 1,333 |

## Researcher papers

Showing 12 of 18.

- [2023 ESC Guidelines for the management of cardiomyopathies](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiomyopathies/)
- [Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy](https://scholariq.org/papers/comparison-of-interstudy-reproducibility-of-cardiovascular-magnetic-resonance/)
- [Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement](https://scholariq.org/papers/myocardial-t1-mapping-and-extracellular-volume-quantification-a-society-for/)
- [Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma](https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/)
- [Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance](https://scholariq.org/papers/interstudy-reproducibility-of-right-ventricular-volumes-function-and-mass-with/)
- [Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis](https://scholariq.org/papers/chemotherapy-and-radiotherapy-in-nasopharyngeal-carcinoma-an-update-of-the-mac/)
- [Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials](https://scholariq.org/papers/meta-analysis-of-phase-ii-cooperative-group-trials-in-metastatic-stage-iv/)
- [Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2](https://scholariq.org/papers/pre-existing-polymerase-specific-t-cells-expand-in-abortive-seronegative-sars/)
- [Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose](https://scholariq.org/papers/prior-sars-cov-2-infection-rescues-b-and-t-cell-responses-to-variants-after/)
- [Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group](https://scholariq.org/papers/meta-analysis-of-chemotherapy-in-head-and-neck-cancer-mach-nc-an-update-on-107/)
- [What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis](https://scholariq.org/papers/what-is-the-best-treatment-of-locally-advanced-nasopharyngeal-carcinoma-an/)
- [Immune boosting by B.1.1.529 <b>(</b> Omicron) depends on previous SARS-CoV-2 exposure](https://scholariq.org/papers/immune-boosting-by-b-1-1-529-b-b-omicron-depends-on-previous-sars-cov-2-exposure/)

## Researcher topics

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Advanced MRI Techniques and Applications](https://scholariq.org/topics/advanced-mri-techniques-and-applications/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
